π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
RATIONALE: Panobinostat and imatinib mesylate may stop the growth of cancer...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-05
Trial ID
NCT00686218
This phase I/IIa trial studies the side effects and best dose of gene-modif...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-07-14
Trial ID
NCT02650986
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT00652860
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and capecitabine...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00524069
The post-extraction pneumatization of the maxillary sinus often compromises...
Status
Completed
Location
Beni-suef university
Start Date
2024-12-01
Trial ID
NCT06681857
Treatments Being Tested
RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, an...
Status
Completed
Location
HealthOne Presbyterian St. Lukes Medical Center
Start Date
2006-01
Trial ID
NCT00322101
Treatments Being Tested